Table 3. PSQI scores of CSU and control groups.
| Scores | CSU (n = 130) | CSU median (min-max) | Control (n = 100) | Control median (min-max) | P value |
|---|---|---|---|---|---|
| SSQ | 1.28 ± 0.10 | 1.00 (0.00-3.00) | 0.92 ± 0.98 | 1.00 (0.00-3.00) | 0.034 |
| SL | 1.55 ± 0.12 | 2.00 (0.00-3.00) | 1.07 ± 0.10 | 1.00 (0.00-3.00) | 0.008 |
| SD | 1.27 ± 0.13 | 1.00 (0.00-3.00) | 0.66 ± 0.12 | 0.00 (0.00-3.00) | 0.003 |
| HSE | 0.66 ± 0.10 | 0.00 (0.00-3.00) | 0.20 ± 0.07 | 0.00 (0.00-2.00) | 0.003 |
| SDis | 1.65 ± 0.84 | 2.00 (0.00-3.00) | 1.25 ± 0.67 | 1.00 (0.00-2.00) | 0.008 |
| USM | 0.35 ± 0.90 | 0.00 (0.00-3.00) | 0.05 ± 0.40 | 0.00 (0.00-3.00) | 0.017 |
| DD | 1.35 ± 0.11 | 1.00 (0.00-3.00) | 0.87 ± 0.10 | 1.00 (0.00-3.00) | 0.005 |
| Global PSQI score | 8.04 ± 0.54 | 7.00 (1.00-17.00) | 5.09 ± 0.44 | 5.00 (0.00-14.00) | < 0.001 |
CSU, chronic spontaneous urticaria; SSQ, subjective sleep quality; SL, sleep latency; SD, sleep duration; HSE, habitual sleep efficiency; SDis, sleep disturbances; USM, use of sleep medications; DD, daytime dysfunction; PSQI, Pittsburgh sleep quality index.